Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Michele Fox

Concepts (268)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cells
9
2025
180
1.580
 Why?
Hematopoietic Stem Cell Transplantation
14
2025
600
1.510
 Why?
Hematopoietic Stem Cell Mobilization
11
2018
60
1.390
 Why?
Multiple Myeloma
27
2025
3013
1.380
 Why?
Blood Component Removal
5
2025
17
0.970
 Why?
Antigens, CD34
10
2025
73
0.820
 Why?
Blood Platelets
5
2017
239
0.780
 Why?
Leukapheresis
4
2025
18
0.640
 Why?
Melphalan
4
2016
176
0.530
 Why?
Bone Marrow Transplantation
4
2016
110
0.510
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1020
0.500
 Why?
Purpura, Thrombotic Thrombocytopenic
2
2018
15
0.500
 Why?
Plasma Exchange
3
2015
25
0.460
 Why?
Transplantation, Autologous
9
2025
479
0.430
 Why?
Fetal Blood
3
2023
78
0.420
 Why?
Cell Separation
2
2013
78
0.390
 Why?
Pregnant Women
1
2023
69
0.370
 Why?
Killer Cells, Natural
2
2015
111
0.350
 Why?
Humans
44
2025
52441
0.340
 Why?
Cell Proliferation
5
2018
1013
0.340
 Why?
Immunotherapy, Adoptive
2
2015
156
0.330
 Why?
Myelodysplastic Syndromes
2
2013
86
0.320
 Why?
Granulocyte Colony-Stimulating Factor
4
2012
64
0.320
 Why?
Thalidomide
4
2016
376
0.300
 Why?
Blood Transfusion
2
2017
126
0.300
 Why?
Blood Specimen Collection
1
2019
35
0.300
 Why?
Blood Volume
1
2019
66
0.300
 Why?
Education, Distance
1
2019
42
0.290
 Why?
Adult
22
2019
14205
0.290
 Why?
Aged
21
2017
10242
0.280
 Why?
Clinical Laboratory Techniques
1
2018
28
0.280
 Why?
Cryopreservation
2
2025
41
0.280
 Why?
Obstetrics
1
2019
89
0.270
 Why?
Leukocytes, Mononuclear
1
2018
122
0.270
 Why?
Cyclooxygenase Inhibitors
1
2017
39
0.270
 Why?
Flow Cytometry
2
2016
396
0.270
 Why?
Blood Grouping and Crossmatching
1
2017
5
0.270
 Why?
Chromosome Aberrations
3
2016
295
0.260
 Why?
Blood Coagulation
1
2017
64
0.260
 Why?
Middle Aged
21
2018
13133
0.260
 Why?
Antibodies
1
2016
144
0.250
 Why?
Aspirin
1
2017
122
0.250
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
123
0.250
 Why?
Erythrocyte Transfusion
2
2015
52
0.240
 Why?
Platelet Aggregation Inhibitors
1
2017
211
0.240
 Why?
Heparin
1
2015
88
0.230
 Why?
Female
22
2023
28277
0.230
 Why?
Hemoglobins, Abnormal
1
2015
4
0.230
 Why?
Thrombocytopenia
1
2015
93
0.220
 Why?
Stem Cell Transplantation
2
2013
188
0.220
 Why?
Factor VIII
1
2014
22
0.220
 Why?
Leukocytes
2
2011
54
0.220
 Why?
ADAM Proteins
1
2014
21
0.220
 Why?
Retrospective Studies
9
2025
6694
0.210
 Why?
Internship and Residency
1
2019
438
0.210
 Why?
Anemia, Sickle Cell
1
2015
101
0.210
 Why?
Follow-Up Studies
8
2024
2294
0.200
 Why?
Male
21
2019
26874
0.200
 Why?
Antiretroviral Therapy, Highly Active
1
2013
32
0.200
 Why?
Leukemia
1
2013
67
0.190
 Why?
Afibrinogenemia
1
2012
5
0.190
 Why?
Neoplasm Recurrence, Local
2
2015
639
0.190
 Why?
Graft Survival
4
2011
157
0.190
 Why?
Prognosis
6
2018
2100
0.180
 Why?
Aldehyde Dehydrogenase
1
2011
24
0.180
 Why?
Transplantation Conditioning
3
2003
93
0.180
 Why?
Boronic Acids
2
2013
180
0.170
 Why?
Pyrazines
2
2013
187
0.170
 Why?
Plateletpheresis
1
2010
7
0.170
 Why?
Blood Preservation
1
2010
27
0.170
 Why?
Transplantation, Homologous
5
2016
151
0.160
 Why?
Blood Proteins
1
2010
84
0.160
 Why?
Anaphylaxis
1
2010
69
0.160
 Why?
Chromosomes, Human, Pair 1
2
2007
95
0.150
 Why?
Cell Survival
5
2011
598
0.150
 Why?
Graft vs Host Disease
5
2003
91
0.150
 Why?
Receptors, KIR
1
2008
11
0.150
 Why?
HIV Infections
1
2013
394
0.140
 Why?
Gene Expression Regulation, Neoplastic
2
2016
853
0.140
 Why?
Myeloablative Agonists
1
2007
32
0.140
 Why?
Cell Movement
2
2006
271
0.130
 Why?
Immunosuppressive Agents
2
2014
248
0.130
 Why?
Treatment Outcome
11
2013
5508
0.130
 Why?
Dexamethasone
3
2024
434
0.130
 Why?
Risk Factors
7
2015
3971
0.120
 Why?
Models, Genetic
1
2006
173
0.120
 Why?
Osteogenesis
2
2006
368
0.120
 Why?
Models, Statistical
1
2007
230
0.120
 Why?
Young Adult
4
2019
4346
0.120
 Why?
Combined Modality Therapy
4
2014
641
0.120
 Why?
Cytokines
2
2006
622
0.120
 Why?
Macrophages
1
2018
357
0.120
 Why?
Platelet Count
3
2017
78
0.120
 Why?
Gene Expression Profiling
2
2007
1099
0.110
 Why?
Enzyme-Linked Immunosorbent Assay
2
2015
234
0.110
 Why?
Incidence
3
2017
1096
0.110
 Why?
Time Factors
1
2010
2987
0.110
 Why?
Antineoplastic Agents
3
2012
1216
0.110
 Why?
Pregnancy
2
2023
2642
0.100
 Why?
Cytotoxicity Tests, Immunologic
2
2016
26
0.100
 Why?
Disease-Free Survival
3
2016
461
0.100
 Why?
Bone Marrow Cells
1
2004
188
0.100
 Why?
Blood Banks
1
2023
18
0.100
 Why?
Bone Diseases
1
2004
91
0.100
 Why?
Metaphase
2
2016
47
0.100
 Why?
Cell Count
3
2011
143
0.100
 Why?
Osteoblasts
1
2006
478
0.100
 Why?
Cyclosporine
1
2003
65
0.100
 Why?
Blood Group Incompatibility
1
2002
4
0.090
 Why?
Tacrolimus
1
2003
61
0.090
 Why?
ABO Blood-Group System
1
2002
16
0.090
 Why?
Universities
1
2023
174
0.090
 Why?
Kaplan-Meier Estimate
3
2007
485
0.090
 Why?
Coculture Techniques
3
2018
142
0.090
 Why?
Osteoclasts
1
2004
423
0.090
 Why?
Models, Biological
1
2004
735
0.090
 Why?
T-Lymphocyte Subsets
1
2001
40
0.080
 Why?
T-Lymphocytes, Cytotoxic
1
2010
64
0.080
 Why?
Lung Diseases
1
2001
84
0.080
 Why?
Prospective Studies
4
2016
2433
0.080
 Why?
Thrombosis
1
2003
250
0.080
 Why?
Heart Failure
1
2006
527
0.080
 Why?
Cancer Vaccines
1
2010
78
0.080
 Why?
Dendritic Cells
1
2010
132
0.080
 Why?
Erythroid Precursor Cells
1
2019
15
0.080
 Why?
Birth Weight
1
2019
127
0.070
 Why?
Hematocrit
1
2018
42
0.070
 Why?
Medical Waste
1
2017
2
0.070
 Why?
Cell Aggregation
1
2017
6
0.070
 Why?
Antineoplastic Agents, Alkylating
2
2008
78
0.070
 Why?
Arkansas
2
2017
2013
0.070
 Why?
Program Evaluation
1
2019
351
0.070
 Why?
Lymphoma
1
2018
71
0.070
 Why?
Lung
1
2001
479
0.070
 Why?
Lymphoma, Follicular
1
2017
27
0.070
 Why?
Logistic Models
2
2017
930
0.070
 Why?
Histocompatibility Antigens Class I
1
2017
47
0.070
 Why?
Adolescent
3
2015
6713
0.060
 Why?
Neoplasms
1
2007
1314
0.060
 Why?
Risk
1
2017
315
0.060
 Why?
Fibrosis
1
2017
198
0.060
 Why?
Dose-Response Relationship, Drug
3
2008
1365
0.060
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
108
0.060
 Why?
Curriculum
1
2019
406
0.060
 Why?
Recurrence
2
2008
680
0.060
 Why?
Hemorrhage
1
2017
225
0.060
 Why?
Hemoglobin J
1
2015
3
0.060
 Why?
Hemoglobin, Sickle
1
2015
5
0.060
 Why?
Hemoglobin C
1
2015
6
0.060
 Why?
Blood Donors
1
2015
21
0.060
 Why?
Diagnosis, Differential
1
2018
1028
0.060
 Why?
Neoplasm Proteins
1
2016
328
0.050
 Why?
Reproducibility of Results
1
2017
1223
0.050
 Why?
Age Factors
3
2005
1120
0.050
 Why?
Autoantibodies
1
2014
118
0.050
 Why?
Blotting, Western
1
2015
587
0.050
 Why?
CD4 Lymphocyte Count
1
2013
33
0.050
 Why?
Viral Load
1
2013
81
0.050
 Why?
Transplantation Chimera
3
2003
16
0.050
 Why?
Acute Disease
1
2013
384
0.050
 Why?
Immunohistochemistry
1
2015
977
0.050
 Why?
Benzylamines
1
2012
15
0.050
 Why?
Receptors, CXCR4
1
2012
31
0.050
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
51
0.050
 Why?
Heterocyclic Compounds
1
2012
29
0.050
 Why?
Infant, Newborn
1
2019
2871
0.040
 Why?
Clinical Protocols
1
2012
106
0.040
 Why?
Immune Tolerance
1
2011
91
0.040
 Why?
Dimethyl Sulfoxide
1
2010
12
0.040
 Why?
Isotonic Solutions
1
2010
21
0.040
 Why?
Platelet Transfusion
1
2010
33
0.040
 Why?
P-Selectin
1
2010
27
0.040
 Why?
Sodium Chloride
1
2010
55
0.040
 Why?
Platelet Aggregation
1
2010
76
0.040
 Why?
Platelet Activation
1
2010
46
0.040
 Why?
Algorithms
2
2005
673
0.040
 Why?
Multivariate Analysis
2
2007
601
0.040
 Why?
Feasibility Studies
1
2011
404
0.040
 Why?
Hypersensitivity
1
2010
80
0.040
 Why?
Haplotypes
1
2008
95
0.040
 Why?
Nitric Oxide Synthase Type II
1
2018
62
0.040
 Why?
Ligands
1
2008
205
0.040
 Why?
Arginase
1
2018
35
0.040
 Why?
Polyethylene Glycols
1
2008
93
0.030
 Why?
Hemoglobins
1
2008
114
0.030
 Why?
Age Distribution
1
2007
176
0.030
 Why?
Cytogenetic Analysis
1
2007
79
0.030
 Why?
Recombinant Proteins
1
2008
490
0.030
 Why?
Tissue Donors
2
2003
126
0.030
 Why?
Antineoplastic Agents, Hormonal
1
2007
56
0.030
 Why?
Multigene Family
1
2006
49
0.030
 Why?
Mice
2
2018
5899
0.030
 Why?
Chromosome Deletion
1
2007
138
0.030
 Why?
Chromosome Mapping
1
2006
149
0.030
 Why?
In Situ Hybridization, Fluorescence
1
2007
262
0.030
 Why?
Angiogenesis Inhibitors
1
2007
183
0.030
 Why?
Cell Line
1
2008
1020
0.030
 Why?
Interleukin-10
1
2006
81
0.030
 Why?
Leukemia, Myeloid, Acute
1
2007
202
0.030
 Why?
Cell Communication
1
2006
74
0.030
 Why?
Neoplasms, Experimental
1
2006
111
0.030
 Why?
Stroke Volume
1
2006
148
0.030
 Why?
Predictive Value of Tests
1
2007
938
0.030
 Why?
Ventricular Dysfunction, Left
1
2006
107
0.030
 Why?
Myocardial Ischemia
1
2006
130
0.030
 Why?
Mice, Transgenic
1
2006
566
0.030
 Why?
Bromodeoxyuridine
1
2004
17
0.030
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
33
0.030
 Why?
Annexin A5
1
2004
14
0.030
 Why?
Culture Media, Conditioned
1
2004
46
0.030
 Why?
Databases, Factual
1
2007
721
0.030
 Why?
Survival Rate
1
2006
944
0.030
 Why?
Tumor Necrosis Factor-alpha
1
2006
390
0.030
 Why?
Phagocytosis
1
2004
54
0.030
 Why?
Chronic Disease
1
2006
579
0.030
 Why?
Cell Division
1
2004
288
0.030
 Why?
Aged, 80 and over
2
2006
3449
0.020
 Why?
Plasmapheresis
1
2003
12
0.020
 Why?
RANK Ligand
1
2004
188
0.020
 Why?
Membrane Glycoproteins
1
2004
239
0.020
 Why?
Interleukin-6
1
2004
271
0.020
 Why?
Salvage Therapy
2
2003
137
0.020
 Why?
NF-kappa B
1
2004
326
0.020
 Why?
Severity of Illness Index
1
2006
1045
0.020
 Why?
Child
1
2015
7194
0.020
 Why?
Cohort Studies
1
2006
1576
0.020
 Why?
Red-Cell Aplasia, Pure
1
2002
7
0.020
 Why?
Carrier Proteins
1
2004
312
0.020
 Why?
Animals
2
2018
13485
0.020
 Why?
Antigens, CD
1
2003
213
0.020
 Why?
Survival Analysis
2
2003
656
0.020
 Why?
Cell Differentiation
1
2004
667
0.020
 Why?
Gene Rearrangement, T-Lymphocyte
1
2001
2
0.020
 Why?
Lymphocyte Count
1
2001
20
0.020
 Why?
Bronchoalveolar Lavage Fluid
1
2001
38
0.020
 Why?
Clone Cells
1
2001
76
0.020
 Why?
Graft Rejection
1
2002
166
0.020
 Why?
Disease Models, Animal
1
2006
1483
0.020
 Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
 Why?
CD40 Ligand
1
2010
14
0.020
 Why?
Hypersensitivity, Delayed
1
2010
18
0.020
 Why?
Interleukin-4
1
2010
41
0.020
 Why?
Immunity, Cellular
1
2010
64
0.020
 Why?
Adjuvants, Immunologic
1
2010
51
0.020
 Why?
Magnetic Resonance Imaging
1
2007
1507
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2001
140
0.020
 Why?
Interferon-gamma
1
2010
169
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2001
580
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2001
165
0.020
 Why?
Transcription, Genetic
1
2001
375
0.020
 Why?
B-Lymphocytes
1
2010
178
0.020
 Why?
Vaccination
1
2010
294
0.020
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
Confidence Intervals
1
2003
158
0.010
 Why?
Lymphocyte Transfusion
1
2003
10
0.010
 Why?
Probability
1
2003
171
0.010
 Why?
Leukocyte Count
1
2003
71
0.010
 Why?
Infusions, Intravenous
1
2003
212
0.010
 Why?
Cyclophosphamide
1
2003
176
0.010
 Why?
Drug Administration Schedule
1
2003
370
0.010
 Why?
Remission Induction
1
2003
218
0.010
 Why?
Administration, Oral
1
2003
455
0.010
 Why?
Neutrophils
1
2003
148
0.010
 Why?
Doxorubicin
1
2003
246
0.010
 Why?
Cisplatin
1
2003
282
0.010
 Why?
Neoplasm Staging
1
2003
768
0.010
 Why?
Drug Resistance, Neoplasm
1
2003
336
0.010
 Why?
Disease Progression
1
2003
870
0.010
 Why?
Fox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (268) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department